Contraindications for ferrous sulfate
Pro Research Analysisby 
Searched over 200M research papers
Contraindications for Ferrous Sulfate
Gastrointestinal Side Effects
Ferrous sulfate is widely used to treat iron deficiency anemia, but it is associated with significant gastrointestinal (GI) side effects. A systematic review and meta-analysis of 43 trials involving 6831 adult participants found that ferrous sulfate significantly increased the risk of GI side effects compared to placebo (OR = 2.32) and intravenous (IV) iron (OR = 3.05). These side effects include nausea, constipation, diarrhea, and abdominal discomfort, which can lead to poor compliance with the treatment .
Specific Populations: Pregnant Women and IBD Patients
Subgroup analyses have shown that pregnant women and patients with inflammatory bowel disease (IBD) are particularly susceptible to the GI side effects of ferrous sulfate. In pregnant women, the odds ratio for GI side effects was 3.33, indicating a significant increase in risk. Similarly, IBD patients also experienced a higher incidence of GI issues when taking ferrous sulfate compared to IV iron (OR = 3.14).
Non-Gastrointestinal Side Effects
While ferrous sulfate is generally well-tolerated in non-anemic, healthy adults, it does not significantly increase the risk of malarial infectivity, pathogenic bacterial proliferation, or other adverse effects. However, in specific populations such as children with autism spectrum disorders, ferrous sulfate did not significantly improve insomnia despite improving iron status, indicating that its benefits may be limited in certain conditions.
Comparative Efficacy and Safety
Comparative studies have shown that other iron supplements may offer similar efficacy with fewer side effects. For instance, lactoferrin, a milk-derived iron-binding glycoprotein, has been found to have better gastrointestinal tolerance and fewer side effects compared to ferrous sulfate. Similarly, ferrous bisglycinate chelate has shown similar efficacy in treating mild non-chemotherapy-induced iron deficiency anemia in cancer patients but with likely lower GI toxicity.
Pediatric Considerations
In infants, ferrous sulfate therapy has been shown to have minimal side effects, comparable to placebo, when administered in moderate doses. Additionally, a study comparing single versus three-times-daily dosing of ferrous sulfate in infants found similar efficacy and minimal side effects, suggesting that a single daily dose may improve adherence without increasing adverse effects.
Drug Interactions
Ferrous sulfate does not significantly affect the pharmacokinetics of mycophenolic acid in kidney transplant patients, indicating that it can be safely co-administered with this immunosuppressive agent without reducing its efficacy.
Conclusion
Ferrous sulfate is an effective treatment for iron deficiency anemia but is associated with significant gastrointestinal side effects, particularly in pregnant women and IBD patients. Alternative iron supplements like lactoferrin and ferrous bisglycinate chelate may offer similar efficacy with fewer side effects. In pediatric populations, ferrous sulfate is generally well-tolerated, and single daily dosing may improve adherence. It is also safe to use in combination with certain medications like mycophenolic acid in kidney transplant patients.
Sources and full results
Most relevant research papers on this topic